Department of Pediatrics Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
Indian J Pediatr. 2013 Apr;80(4):326-33. doi: 10.1007/s12098-013-0987-x. Epub 2013 Mar 17.
Upper gastrointestinal bleeding (UGIB) is a potentially life threatening medical emergency requiring an appropriate diagnostic and therapeutic approach. Therefore, the primary focus in a child with UGIB is resuscitation and stabilization followed by a diagnostic evaluation. The differential diagnosis of UGIB in children is determined by age and severity of bleed. In infants and toddlers mucosal bleed (gastritis and stress ulcers) is a common cause. In children above 2 y variceal bleeding due to Extra-Hepatic Portal Venous Obstruction (EHPVO) is the commonest cause of significant UGIB in developing countries as against peptic ulcer in the developed countries. Upper gastrointestinal endoscopy is the most accurate and useful diagnostic tool to evaluate UGIB in children. Parenteral vitamin K (infants, 1-2 mg/dose; children, 5-10 mg) and parenteral Proton Pump Inhibitors (PPI's), should be administered empirically in case of a major UGIB. Octreotide infusion is useful in control of significant UGIB due to variceal hemorrhage. A temporarily placed, Sengstaken-Blakemore tube can be life saving if pharmacologic/ endoscopic methods fail to control variceal bleeding. Therapy in patients having mucosal bleed is directed at neutralization and/or prevention of gastric acid release; High dose Proton Pump Inhibitors (PPIs, Pantoprazole) are more efficacious than H2 receptor antagonists for this purpose.
上消化道出血 (UGIB) 是一种潜在的危及生命的医疗紧急情况,需要采取适当的诊断和治疗方法。因此,儿童 UGIB 的主要重点是复苏和稳定,然后进行诊断评估。儿童 UGIB 的鉴别诊断取决于年龄和出血的严重程度。在婴儿和幼儿中,黏膜出血(胃炎和应激性溃疡)是常见的原因。在 2 岁以上的儿童中,由于肝外门静脉阻塞 (EHPVO) 引起的静脉曲张出血是发展中国家儿童发生重大 UGIB 的最常见原因,而在发达国家则是消化性溃疡。上消化道内镜检查是评估儿童 UGIB 最准确和有用的诊断工具。如果发生重大 UGIB,应根据情况给予静脉注射维生素 K(婴儿 1-2mg/剂;儿童 5-10mg)和静脉注射质子泵抑制剂 (PPI)。奥曲肽输注可有效控制因静脉曲张出血引起的显著 UGIB。如果药物/内镜方法无法控制静脉曲张出血,暂时放置的 Sengstaken-Blakemore 管可挽救生命。对于黏膜出血的患者,治疗旨在中和和/或预防胃酸释放;高剂量质子泵抑制剂 (PPI,泮托拉唑) 比 H2 受体拮抗剂更有效。